Adele M. Mount
Walter and Eliza Hall Institute of Medical Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Adele M. Mount.
Nature Immunology | 2006
Nicholas S. Wilson; Georg M. N. Behrens; Rachel J. Lundie; Christopher M. Smith; Jason Waithman; Louise Young; Simon P. Forehan; Adele M. Mount; Raymond J. Steptoe; Ken Shortman; Tania F. de Koning-Ward; Gabrielle T. Belz; Francis R. Carbone; Brendan S. Crabb; William R. Heath; Jose A. Villadangos
The mechanisms responsible for the immunosuppression associated with sepsis or some chronic blood infections remain poorly understood. Here we show that infection with a malaria parasite (Plasmodium berghei) or simple systemic exposure to bacterial or viral Toll-like receptor ligands inhibited cross-priming. Reduced cross-priming was a consequence of downregulation of cross-presentation by activated dendritic cells due to systemic activation that did not otherwise globally inhibit T cell proliferation. Although activated dendritic cells retained their capacity to present viral antigens via the endogenous major histocompatibility complex class I processing pathway, antiviral responses were greatly impaired in mice exposed to Toll-like receptor ligands. This is consistent with a key function for cross-presentation in antiviral immunity and helps explain the immunosuppressive effects of systemic infection. Moreover, inhibition of cross-presentation was overcome by injection of dendritic cells bearing antigen, which provides a new strategy for generating immunity during immunosuppressive blood infections.
Nature Immunology | 2008
Louise J. Young; Nicholas S. Wilson; Petra Schnorrer; Anna I Proietto; Toine ten Broeke; Yohei Matsuki; Adele M. Mount; Gabrielle T. Belz; Meredith O'Keeffe; Mari Ohmura-Hoshino; Satoshi Ishido; Willem Stoorvogel; William R. Heath; Ken Shortman; Jose A. Villadangos
The importance of conventional dendritic cells (cDCs) in the processing and presentation of antigen is well established, but the contribution of plasmacytoid dendritic cells (pDCs) to these processes, and hence to T cell immunity, remains unclear. Here we showed that unlike cDCs, pDCs continued to synthesize major histocompatibility complex (MHC) class II molecules and the MHC class II ubiquitin ligase MARCH1 long after activation. Sustained MHC class II–peptide complex formation, ubiquitination and turnover rendered pDCs inefficient in the presentation of exogenous antigens but enabled pDCs to continuously present endogenous viral antigens in their activated state. As the antigen-presenting abilities of cDCs and pDCs are fundamentally distinct, these two cell types may activate largely nonoverlapping repertoires of CD4+ T cells.
Journal of Experimental Medicine | 2012
Alex Karnowski; Stéphane Chevrier; Gabrielle T. Belz; Adele M. Mount; Dianne Emslie; Kathy D’Costa; David M. Tarlinton; Axel Kallies; Lynn M. Corcoran
Transcriptional activator Oct2 and cofactor OBF-1 regulate B cell IL-6 to induce T cell production of IL-21, to support Tfh cell development in antiviral immunity.
The EMBO Journal | 2011
Jacob T. Jackson; Yifang Hu; Ruijie Liu; Frederick Masson; Angela D'Amico; Sebastian Carotta; Annie Xin; Mary J Camilleri; Adele M. Mount; Axel Kallies; Li Wu; Gordon K. Smyth; Stephen L. Nutt; Gabrielle T. Belz
Dendritic cells (DCs) have critical roles in the induction of the adaptive immune response. The transcription factors Id2, Batf3 and Irf‐8 are required for many aspects of murine DC differentiation including development of CD8α+ and CD103+ DCs. How they regulate DC subset specification is not completely understood. Using an Id2‐GFP reporter system, we show that Id2 is broadly expressed in all cDC subsets with the highest expression in CD103+ and CD8α+ lineages. Notably, CD103+ DCs were the only DC able to constitutively cross‐present cell‐associated antigens in vitro. Irf‐8 deficiency affected loss of development of virtually all conventional DCs (cDCs) while Batf3 deficiency resulted in the development of Sirp‐α− DCs that had impaired survival. Exposure to GM‐CSF during differentiation induced expression of CD103 in Id2‐GFP+ DCs. It did not restore cross‐presenting capacity to Batf3−/− or CD103−Sirp‐α−DCs in vitro. Thus, Irf‐8 and Batf3 regulate distinct stages in DC differentiation during the development of cDCs. Genetic mapping DC subset differentiation using Id2‐GFP may have broad implications in understanding the interplay of DC subsets during protective and pathological immune responses.
Immunity | 2009
Susan Johnson; Yifan Zhan; Robyn M. Sutherland; Adele M. Mount; Sammy Bedoui; Jamie L. Brady; Emma M. Carrington; Lorena E. Brown; Gabrielle T. Belz; William R. Heath; Andrew M. Lew
CD40L (CD154) on CD4(+) T cells has been shown to license dendritic cells (DCs) via CD40 to prime cytotoxic T lymphocyte (CTL) responses. We found that the converse (CD40L on DCs) was also important. Anti-CD40L treatment decreased endogenous CTL responses to both ovalbumin and influenza infection even in the absence of CD4(+) T cells. DCs expressed CD40L upon stimulation with agonists to Toll-like receptor 3 (TLR3) and TLR9. Moreover, influenza infection, which stimulates CTLs without help, upregulated CD40L on DCs, but herpes simplex infection, which elicits CTLs through help, did not. CD40L-deficient (Cd40lg(-/-)) DCs are suboptimal both in vivo in bone marrow chimera experiments and in vitro in mixed lymphocyte reactions. In contrast, Cd40lg(-/-) CD8(+) T cells killed as effectively as wild-type cells. Thus, CD40L upregulation on DCs promoted optimal priming of CD8(+) T cells without CD4(+) T cells, providing a mechanism by which pathogens may elicit helper-independent CTL immunity.
Proceedings of the National Academy of Sciences of the United States of America | 2007
Louise J. Young; Nicholas S. Wilson; Petra Schnorrer; Adele M. Mount; Rachel J. Lundie; Nicole L. La Gruta; Brendan S. Crabb; Gabrielle T. Belz; William R. Heath; Jose A. Villadangos
When dendritic cells (DCs) encounter signals associated with infection or inflammation, they become activated and undergo maturation. Mature DCs are very efficient at presenting antigens captured in association with their activating signal but fail to present subsequently encountered antigens, at least in vitro. Such impairment of MHC class II (MHC II) antigen presentation has generally been thought to be a consequence of down-regulation of endocytosis, so it might be expected that antigens synthesized by the DCs themselves (for instance, viral antigens) would still be presented by mature DCs. Here, we show that DCs matured in vivo could still capture and process soluble antigens, but were unable to present peptides derived from these antigens. Furthermore, presentation of viral antigens synthesized by the DCs themselves was also severely impaired. Indeed, i.v. injection of pathogen mimics, which caused systemic DC activation in vivo, impaired the induction of CD4 T cell responses against subsequently encountered protein antigens. This immunosuppressed state could be reversed by adoptive transfer of DCs loaded exogenously with antigens, demonstrating that impairment of CD4 T cell responses was due to lack of antigen presentation rather than to overt suppression of T cell activation. The biochemical mechanism underlying this phenomenon was the down-regulation of MHC II–peptide complex formation that accompanied DC maturation. These observations have important implications for the design of prophylactic and therapeutic DC vaccines and contribute to the understanding of the mechanisms causing immunosuppression during systemic blood infections.
European Journal of Immunology | 2006
Gabrielle T. Belz; Nicholas S. Wilson; Christopher M. Smith; Adele M. Mount; Francis R. Carbone; William R. Heath
While naive CD8+ T cells have been shown to require bone marrow‐derived dendritic cells (DC) to initiate immunity, such a requirement for memory CD8+ T cells has had limited assessment. By generating bone marrow chimeras that express the appropriate antigen‐presenting molecules on either radiation‐sensitive bone marrow‐derived or radiation‐resistant non‐bone marrow‐derived compartments, we showed that both primary and secondary immune responses to influenza virus infection of the lung were initiated in the draining LN. This required cells of bone marrow origin, most likely DC, for optimal expansion within the secondary lymphoid compartment. This was similarly the case with HSV‐1 infection of the skin. As Langerhans cells are radioresistant, unlike other DC populations, these studies also demonstrate that the radiosensitive DC responsible for secondary expansion of HSV‐specific memory are not Langerhans cells.
PLOS ONE | 2008
Adele M. Mount; Christopher M. Smith; Fiona Kupresanin; Kristina Stoermer; William R. Heath; Gabrielle T. Belz
Dendritic cells (DC) are a heterogeneous cell population that bridge the innate and adaptive immune systems. CD8alpha DC play a prominent, and sometimes exclusive, role in driving amplification of CD8(+) T cells during a viral infection. Whether this reliance on a single subset of DC also applies for CD4(+) T cell activation is unknown. We used a direct ex vivo antigen presentation assay to probe the capacity of flow cytometrically purified DC populations to drive amplification of CD4(+) and CD8(+) T cells following infection with influenza virus by different routes. This study examined the contributions of non-CD8alpha DC populations in the amplification of CD8(+) and CD4(+) T cells in cutaneous and systemic influenza viral infections. We confirmed that in vivo, effective immune responses for CD8(+) T cells are dominated by presentation of antigen by CD8alpha DC but can involve non-CD8alpha DC. In contrast, CD4(+) T cell responses relied more heavily on the contributions of dermal DC migrating from peripheral lymphoid tissues following cutaneous infection, and CD4 DC in the spleen after systemic infection. CD4(+) T cell priming by DC subsets that is dependent upon the route of administration raises the possibility that vaccination approaches could be tailored to prime helper T cell immunity.
Journal of Immunology | 2013
Frederick Masson; Martina Minnich; Moshe Olshansky; Ivan Bilic; Adele M. Mount; Axel Kallies; Terence P. Speed; Meinrad Busslinger; Stephen L. Nutt; Gabrielle T. Belz
The transcription factor inhibitor of DNA binding (Id)2 modulates T cell fate decisions, but the molecular mechanism underpinning this regulation is unclear. In this study we show that loss of Id2 cripples effector differentiation and instead programs CD8+ T cells to adopt a memory fate with increased Eomesodermin and Tcf7 expression. We demonstrate that Id2 restrains CD8+ T cell memory differentiation by inhibiting E2A-mediated direct activation of Tcf7 and that Id2 expression level mirrors T cell memory recall capacity. As a result of the defective effector differentiation, Id2-deficient CD8+ T cells fail to induce sufficient Tbx21 expression to generate short-lived effector CD8+ T cells. Our findings reveal that the Id2/E2A axis orchestrates T cell differentiation through the induction or repression of downstream transcription factors essential for effector and memory T cell differentiation.
Immunology and Cell Biology | 2008
Frederick Masson; Adele M. Mount; Nicholas S. Wilson; Gabrielle T. Belz
Protective immunity against viral pathogens depends on the generation and maintenance of a small population of memory CD8+ T cells. Successful memory cell generation begins with early interactions between naïve T cell and dendritic cells (DCs) within the inflammatory milieu of the secondary lymphoid tissues. Recent insights into the role of different populations of DCs, and kinetics of antigen presentation, during viral infections have helped to understand how DCs can shape the immune response. Here, we review the recent progress that has been made towards defining how specific DC subsets drive effector CD8+ T‐cell expansion and differentiation into memory cells. Further, we endeavour to examine how the molecular signals imparted by DCs coordinate to generate protective CD8+ T‐cell immunity.